Wen Shuhao, a Chinese physicist at MIT, made notable contributions to the accelerated development of Pfizer’s Covid oral medication, Paxlovid, and is now setting his sights on enhancing solar panel and EV battery technologies through AI. However, his groundbreaking work raises questions about intellectual property and the security of technological advancements in critical sectors, amidst heightened tensions between the U.S. and China over technology transfer and cybersecurity.
Chinese Scientist at MIT Turns to AI for Advancements in Drug Development and Energy, Amid Growing Concerns over Tech Security
All Versions
Jan-29
Ai
Score: 0.50
Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help make better solar panels and EV batteries.
From Forbes
Jan-29
Ai
Left Variant
Score: 0.20
In a significant step forward for sustainable technology and healthcare, Wen Shuhao, leveraging his expertise at the intersection of AI and science, has contributed substantially to the swift development of the life-saving Pfizer Covid oral treatment, Paxlovid. Currently, as the chairman of Xtalpi, he is pioneering the use of AI to revolutionize solar panel and EV battery technology, aligning perfectly with global efforts to combat climate change and transition towards renewable energy sources.
From Forbes